Nektar Therapeutics (NKTR) financial statements (2020 and earlier)

Company profile

Business Address 455 MISSION BAY BOULEVARD SOUTH
SAN FRANCISCO, CA 94158
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,3251,335296389309238237
Cash and cash equivalents96195560561239
Short-term investments1,2281,140291329253225198
Restricted cash and investments     25 
Receivables37435162042
Inventory, net of allowances, customer advances and progress billings13111111111313
Inventory13111111111313
Other current assets152115101095
Other undisclosed current assets3226     
Total current assets:1,4221,438327426350288258
Noncurrent Assets
Property, plant and equipment65494766717067
Long-term investments and receivables27958357    
Long-term investments27958357    
Intangible assets, net (including goodwill)77777777777777
Goodwill77777777777777
Restricted cash and investments      25
Other noncurrent assets1411478
Other undisclosed noncurrent assets134      
Total noncurrent assets:556712182143152153177
TOTAL ASSETS:1,9772,150509569502442435
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities46292730172230
Accounts payable19653239
Accrued liabilities119105466
Employee-related liabilities11108186614
Interest and dividends payable444447 
Debt249  3554
Deferred revenue and credits1914212424
Contract with customer, liability614
Other liabilities100410614
Other undisclosed current liabilities52399208827
Total current liabilities:354825672616498
Noncurrent Liabilities
Long-term debt and lease obligation 247245246243129133
Long-term debt, excluding current maturities 247245243242125125
Capital lease obligations  2148
Liabilities, other than long-term debt33031638192102
Deferred revenue and credits2558717782
Contract with customer, liability311
Deferred rent credit 9
Other liabilities11065101519
Other undisclosed noncurrent liabilities215748999111120192
Total noncurrent liabilities:218351365409434341426
Total liabilities:572433421481496405524
Stockholders' equity
Stockholders' equity attributable to parent1,4051,7188888636(90)
Common stock0000000
Additional paid in capital3,2713,1482,2082,1111,8761,8241,644
Accumulated other comprehensive loss(1)(6)(2)(2)(2)(2)(1)
Accumulated deficit(1,865)(1,424)(2,118)(2,021)(1,867)(1,786)(1,732)
Total stockholders' equity:1,4051,7188888636(90)
TOTAL LIABILITIES AND EQUITY:1,9772,150509569502442435

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues1151,193308165231201149
Revenue, net6675432546
Cost of revenue(21)(24)(47)(30)(34)(32)(43)
Cost of goods and services sold(21)(24)(31)(30)(34)(32)(43)
Gross profit:931,169261135197169106
Operating expenses(533)(481)(321)(248)(226)(202)(245)
Other undisclosed operating income     1618
Operating income (loss):(440)688(60)(113)(29)(16)(120)
Nonoperating expense(0)(5)(36)(40)(51)(38)(40)
Other nonoperating income463852210
Interest and debt expense(21)(22)(22)(22)(14)(18)(18)
Other undisclosed income from continuing operations before equity method investments, income taxes     1818
Income (loss) from continuing operations before equity method investments, income taxes:(461)661(118)(175)(95)(54)(160)
Other undisclosed income from continuing operations before income taxes2122222214  
Income (loss) from continuing operations before income taxes:(440)683(96)(153)(81)(54)(160)
Income tax expense (benefit)(1)(1)(1)(1)(1)1(2)
Net income (loss) available to common stockholders, diluted:(441)681(97)(154)(81)(54)(162)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(441)681(97)(154)(81)(54)(162)
Other comprehensive income (loss)5(4)0(0)(1)(0)(1)
Comprehensive income (loss), net of tax, attributable to parent:(435)677(96)(154)(82)(54)(163)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: